FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to a hepatoprotective agent. Hepatoprotective agent based on the lipid fraction of the alcohol extract of the thallus of the Ahnfeltia tobuchensis (Kanno et Matsubara) Makijenko, Rodophyta section, the order of Ahnfeltiales, family Ahnfeltiaceae, containing up to 69 % membrane-active lipid components, including at least 30 % glycolipids and at least 26 % essential phospholipids with a content of poly-unsaturated fatty acids of the family n-9, n-6 and n-3 not less than 66 % of the total amount of fatty acids.
EFFECT: above-described agent has an effective hepatoprotective effect, promotes the accelerated recovery of cascades of metabolic reactions, ensuring the normalization of biochemical parameters of carbohydrate and lipid metabolism.
1 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
HEPATOPROTECTIVE AGENT FROM ALGAE | 2013 |
|
RU2528898C1 |
LIPID-CORRECTING AGENT OF SEAWEED | 2021 |
|
RU2767908C1 |
ALGAE HEPATOPROTECTIVE AGENT | 2016 |
|
RU2616253C1 |
HEPATOPROTECTOR | 2007 |
|
RU2329056C1 |
MEDICATION POSSESSING HEPATOPROTECTIVE ACTION | 2009 |
|
RU2405562C1 |
METHOD FOR REDUCING TOXIC DAMAGE OF RATS' LIVER BY A CARBON TETRACHLORATED | 2018 |
|
RU2678313C1 |
HEPATOPROTECTOR | 2011 |
|
RU2454243C1 |
AGENT ELICITING HEPATOPROTECTIVE EFFECT | 2000 |
|
RU2177330C1 |
THERAPEUTIC AGENT FOR PREVENTING AND TREATING CHRONIC LIVER DISEASES | 2012 |
|
RU2526172C2 |
AGENT EXHIBITING HEPATOPROTECTIVE EFFECT | 2000 |
|
RU2179031C1 |
Authors
Dates
2018-09-19—Published
2017-12-27—Filed